Coltuximab ravtansine | m-entrepreneurship.com

Product Name :
Coltuximab ravtansine

Search keywords :
Coltuximab

drugId :
null

Target Vo:
B-lymphocyte antigen CD19

Target Vo Short Name :
CD19

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunogen Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Lymphoma, Non-Hodgkin

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NF-κB p105/p50 Antibody
CD8 alpha Antibody
E-Selectin Antibody: E-Selectin Antibody is an unconjugated, approximately 65 kDa, rabbit-derived, anti-E-Selectin polyclonal antibody. E-Selectin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, pig, and predicted: rat, chicken, dog, horse, rabbit background without labeling.

Author: Betaine hydrochloride

Related Posts